LENZ Therapeutics Cash Flow Statement (2022-2023) | LENZ

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Operating Activities
Depreciation and Depletion 0.40M0.60M0.70M0.70M0.70M0.80M0.80M0.10M
Share-based Compensation 3.34M3.36M3.21M3.62M0.14M2.85M2.16M0.52M
Gains from Sales and Divestitures 0.40M0.45M0.50M0.55M0.60M0.65M0.70M
Gains from Investment Securities 0.02M0.14M0.02M0.17M0.01M
Asset Writedowns and Impairment 7.21M13.35M
Non-cash Items 0.79M1.48M0.77M0.79M1.21M1.47M4.23M
Cash from Operations -21.24M-22.09M-22.22M-22.43M-12.80M-13.52M-13.09M-20.97M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.04M-0.04M0.56M1.12M0.02M0.53M0.51M
Depreciation & Amortization (CF) 0.44M0.58M0.65M0.68M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in Account Payables 0.58M0.30M0.39M-1.08M-0.57M-1.63M1.97M1.09M
Change in Accured Expenses -1.67M1.16M1.17M0.45M-0.15M2.98M3.34M1.62M
Investing Activities
Capital Expenditures 3.27M1.39M0.92M1.02M0.01M0.02M
Sales of Property, Plant and Equipment 0.89M0.68M
Change in Acquisitions & Divestments 90.00M80.25M1.50M21.00M
Cash from Investing Activities -170.67M-88.22M3.50M13.52M-0.01M-26.88M-17.91M15.17M
Financing Activities
Other financing activities 1.91M
Change in Capital Stock
Shares Issued 0.24M0.20M
Preferred Shares Issued 82.98M
Misc.
Cash from Financing Activities 0.41M-0.06M0.24M83.18M-0.57M-1.91M
Change in Cash -191.91M-109.90M-18.78M-8.66M70.38M-40.40M-31.57M-7.71M
Beginning Cash Balance 376.98M185.07M75.17M56.39M-62.41M168.91M214.56M7.71M
Free Cash Flow -24.51M-23.48M-23.13M-23.45M-12.80M-13.55M-13.09M-20.97M
Net Cash Flow -191.91M-109.90M-18.78M-8.66M70.38M-40.40M-31.57M-7.71M